securities fraud

Class action lawsuit filed against $HCA alleging materially false statements regarding due diligence, loan origination, and portfolio valuation between May 2025 and February 2026.

Class action lawsuit filed against Lufax Holding Ltd alleging securities fraud and false financial statements. Coverage period spans April 2023 to January 2025.

Class action lawsuit filed against $SNOW alleges securities fraud over nondisclosure of product efficiency changes impacting consumption and revenues during June 2023-February 2024 period.

Class action lawsuit filed against Coty over alleged misstatements on beauty market performance, margin compression, and segment growth between November 2025 and February 2026. Lead plaintiff deadline: May 22, 2026.

Bronstein, Gewirtz & Grossman filed class action against Super Micro Computer alleging undisclosed China sales violating export controls. Shareholders purchased between April 30, 2024 and March 19, 2026 may join; lead plaintiff deadline May 26, 2026.

Lufax Holding Ltd ($LU) faces class action lawsuit alleging materially false statements, weak internal controls, and misstated financials from April 2023 to January 2025.

BlackRock TCP Capital Corp. faces class action lawsuit alleging materially false statements on valuations and NAV. Shareholders can register as lead plaintiff by April 6, 2026.

Schall Law Firm launches class action against $COTY for allegedly making false statements about fiscal 2026 growth prospects while Consumer Beauty segment underperformed.

Disc Medicine faces securities probe after FDA rejects bitopertin drug; stock slides 22% on February 13, 2026.

The Portnoy Law Firm investigates $TNDM after a 19.9% stock plunge triggered by insulin pump malfunction disclosures that could halt insulin delivery.

Rosen Law Firm filed a class action lawsuit against ImmunityBio ($IBRX), alleging founder Patrick Soon-Shiong materially overstated Anktiva's capabilities, impacting investors.

Class action lawsuit filed against ImmunityBio for allegedly making false statements about cancer treatment Anktiva. FDA issued warning letter; stock fell 21% after disclosure.

Kirby McInerney files class action against Power Solutions International for allegedly overstating data center demand and understating manufacturing costs, citing margin deterioration.

PayPal faces securities fraud lawsuit over false growth claims. Stock dropped 20.3% after surprise CEO change and missed earnings. Investors have until April 20, 2026, for lead plaintiff status.

Johnson Fistel investigates Lumexa Imaging Holdings for potential securities fraud following March 2026 disclosures that triggered significant stock declines. Affected investors are encouraged to contact the firm about recovery options.

Trip.com investors can file claims by May 11, 2026, in lawsuit alleging the company concealed Chinese antitrust investigation and monopolistic practice risks.

Portnoy Law Firm launches class action against $SMCI over alleged unlicensed server exports to China. Stock plunges 33% after DOJ indictment of three individuals.

Grocery Outlet faces securities fraud lawsuit after missing March 2026 guidance and announcing 36 store closures with $110M impairment charge, triggering 27.9% stock collapse.

Bragar Eagel & Squire announces class action lawsuit against Concorde International ($CIGL) for alleged stock fraud involving social media misinformation, fake financial professionals, and insider dumping.

Class action lawsuit filed against $PSIX alleging false statements about data center sales capture and understated manufacturing costs. Investor deadline set for May 19, 2026.